Muscle-building supplements may be associated with testicular cancer
the ONA take:
According to a new study published in the British Journal of Cancer, researchers have found that men who reported taking muscle-building supplements, such as powders and pills with androstenedione or creatine, had a significantly increased likelihood of developing testicular cancer compared with men who did not use those supplements.
For the study, researchers surveyed about 900 men from Connecticut and Massachusetts. Of those, 356 had been diagnosed with testicular germ cell cancer while 513 had not been diagnosed with testicular cancer.
Participants were were asked about exercise, drinking, and smoking habits, family history of testicular cancer, supplement use, and prior injury to their groin or testicles.
Results showed that men who had used supplements had a 65% higher risk of developing testicular cancer than those who did not.
Those who used more than one kind of supplement had a 177% higher risk than those that did not use supplements, and participants that used supplements for at least 3 years had a 156% higher risk.
Researchers also found that men who started using supplements at or before age 25 had a 121% higher risk of developing testicular cancer.
Taking muscle-building supplements significantly increases likelihood of developing testicular cancer.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|